Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial

Published:2017-08-04 Issue:9 Volume:69 Page:1903-1913
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Dalbeth Nicola¹,Jones Graeme²,Terkeltaub Robert³,Khanna Dinesh⁴,Kopicko Jeff⁵,Bhakta Nihar⁵,Adler Scott⁶,Fung Maple⁵,Storgard Chris⁵,Baumgartner Scott⁵,Perez-Ruiz Fernando⁷

Affiliation:

1. University of Auckland; Auckland New Zealand

2. University of Tasmania; Hobart Tasmania Australia

3. University of California; San Diego

4. University of Michigan; Ann Arbor

5. Ardea Biosciences, Inc.; San Diego California

6. AstraZeneca Pharmaceuticals; Gaithersburg Maryland

7. Hospital Universitario Cruces; Baracaldo Spain

Funder

Ardea Biosciences

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Reference31 articles.

1. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia;Khanna;Arthritis Care Res (Hoboken),2012

2. 2016 updated EULAR evidence-based recommendations for the management of gout;Richette;Ann Rheum Dis,2017

3. Treat-to-target (T2T) recommendations for gout;Kiltz;Ann Rheum Dis,2016

4. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol;Pacher;Pharmacol Rev,2006

5. Febuxostat compared with allopurinol in patients with hyperuricemia and gout;Becker;N Engl J Med,2005

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Challenges and Emerging Therapies in the Treatment of Gout;Current Rheumatology Reviews;2024-07-22

2. Design, synthesis, and biological evaluation of 3-phenyl substituted pyridine derivatives as potential dual inhibitors of XOR and URAT1;European Journal of Medicinal Chemistry;2024-05

3. Gout Management Using Nanocarrier Systems: A Review;ACS Applied Nano Materials;2024-04-22

4. Comparative Risk of Gout Flares When Initiating or Escalating Various Urate‐Lowering Therapy: A Systematic Review With Network Meta‐Analysis;Arthritis Care & Research;2024-03-14

5. Cardiovascular Safety of Febuxostat in Patients With Gout or Hyperuricemia;JCR: Journal of Clinical Rheumatology;2023-12-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3